Collectively, these data suggest that liver‐specific PMVK deletion significantly slows HCC development by reducing cell proliferation and cholesterol and triglyceride levels whereas PMVK‐mediated phosphorylation of β‐catenin Ser184 strongly promotes tumor growth. The gene discussed is PMVK; the disease is hepatocellular carcinoma.